In contrast, in patients with ACC, KRAS and TP53 were significantly less frequently detected in comparison with the other three tumor types, at 13.6 and 15.9%, respectively (p < 0.01 for TP53 between ACC and ACP, p < 0.001 for the rest). This evidence concerns the gene TP53 and adrenal cortex carcinoma.